Skip to main content
  • About Us
  • Investors
  • Careers
  • Contact us
Choose your market:
United Kingdom
  • Global / English
  • Albania / Gjuha shqipe
  • Algeria / Français
  • Argentina / Español
  • Australia / English
  • Austria / Deutsch
  • Bahrain / English
  • Belgium / English
  • Bolivia / Español
  • Bosnia-Herzegovina / BS
  • Bosnia-Herzegovina / EN
  • Brazil / Português
  • Bulgaria / Български
  • Canada / English
  • Canada / Français
  • Chile / Español
  • China / 简体中文
  • China / English
  • Colombia / Español
  • Costa Rica / Español
  • Croatia / Hrvatski jezik
  • Croatia / English
  • Cyprus / English
  • Czech Republic / český
  • Denmark / Dansk
  • Denmark / English
  • Dominican Republic / ES
  • Ecuador / Español
  • Egypt / English
  • El Salvador / Español
  • France / Français
  • Germany / Deutsch
  • Ghana / English
  • Guatemala / Español
  • Hong Kong SAR China / English
  • Hungary / Magyar nyelv
  • India / English
  • Indonesia / English
  • Iraq / English
  • Ireland / English
  • Israel / Hebrew
  • Italy / Italiano
  • Japan / 日本語
  • Jordan / English
  • Kazakhstan / Pусский
  • Kenya / English
  • Kosovo / Gjuha shqipe
  • Kosovo / Srpski
  • Kuwait / English
  • Lebanon / English
  • Macedonia / Македонски јазик
  • Macedonia / Gjuha shqipe
  • Malaysia / English
  • México / Español
  • Montenegro / Montenegrin
  • Morocco / Français
  • Mozambique / Portuguese
  • Netherlands / Nederlands
  • Netherlands / English
  • New Zealand / English
  • Nigeria / English
  • Norway / Norsk
  • Pakistan / English
  • Panama / Español
  • Peru / Español
  • Philippines / English
  • Poland / Polski
  • Portugal / Português
  • Puerto Rico / English
  • Qatar / English
  • Romania / Română
  • Romania / English
  • Russia / Pусский
  • Saudi Arabia / English
  • Serbia / Srpski
  • Singapore / English
  • Slovakia / Slovenský
  • Slovenia / Slovenščina
  • Slovenia / English
  • South Africa / English
  • South Korea / 한국어
  • Spain / Español
  • Sweden / Svenska
  • Switzerland / English
  • Switzerland / Deutsch
  • Taiwan / English
  • Tanzania / English
  • Thailand / English
  • Tunisia / Français
  • Türkiye / Türkçe
  • UAE / English
  • Uganda / English
  • Ukraine / Українська мова
  • Ukraine / English
  • United Kingdom / English
  • United States / English
  • Venezuela / Español
  • Vietnam / English
  • Zambia / English
  • News & Events
    • All
    • News & Polls
    • Events
    • Webinars
    • Newsletter
  • Innovation & Knowledge
    • All
    • Media & Brand Communication
    • Consumer & Shopper
    • Customer Experience
    • Society
    • New Services
  • Our Solutions
    • All
  • Ipsos.digital platform
  • ESG
  • About us
  • Investors
  • Careers
  • Contact us
  • Ipsos
  • Search

Search

Sort by Date Relevance
We found 187 results matching with your query. Refine by
  • Society

    Fear And Reassurance: Communications And The NHS

    Two recent issues of public concern over healthcare, though very different in their details, demonstrate some common threads in the way public opinion on such issues arises and the importance of good communications in averting such potential crises.

    15 February 2002
  • Society

    Low Support For Baby Research

    Despite 1 in 3 (36%) people identifying that medical research has had more impact on people's lives than any other development over the last 50 years, only 7% wanted to see the greatest medical advances over the next 50 years made into conditions relating to pregnancy and birth. This would include such complications as premature birth.

    28 November 2001
  • Society

    New Figures Suggest Worsening Public Complacency Of HIV Threat In Britain

    A MORI poll published today by NAT (National AIDS Trust) to mark World AIDS Day finds that two-thirds of the public in Great Britain have not changed their lifestyle in response to HIV/AIDS despite the vast majority knowing that unprotected sex is the main cause of HIV infection.

    1 December 2000
  • Society

    Food For Thought: Helping Prevent Disabilities In Babies

    Only about half of British women of childbearing age are aware that folic acid can help prevent spina bifida in unborn babies, according to a new survey.

    26 October 2000
  • Society

    Public Support For Controversial Technologies Could Increase If Applications Are Explained

    A new public opinion survey has shown that support for controversial technologies in the Life Sciences may be increased if the public is given proof that those developments are necessary in order to achieve certain benefits. A poll conducted by MORI and commissioned by Novartis UK Ltd shows that if the public can see concrete benefits arising from research it is more willing to support new technologies.

    8 September 1999
  • Society

    Attitudes Towards Experimentation on Live Animals - Toplines

    Q1.a On balance, do you agree or disagree that scientists should be allowed to conduct any experiments on live animals?
    Base: All Version 1 (949: split-sample)

    19 May 1999
  • Society

    Attitudes Towards Experimentation on Live Animals

    What would it take for you to agree that a mouse or monkey should suffer pain or even die? To cure a life-threatening disease? Or would no scientific gain justify the animal's suffering?

    19 May 1999
Pagination
  • First page 1
  • Page 10 10
  • Previous page <
  • Current page 19

Refine by

REFINE YOUR SEARCH FOR KEY WORD

  • News & Events
  • Innovation & Knowledge
    • Consumer & Shopper
    • Corporate
    • Customer Experience
    • New Services
    • Society
  • Citizens
  • Consumers & Brands
  • Customers & Employees
  • Doctors & Patients
  • Capabilities
  • About Us
  • Contact Us
  • Press
  • Investors
  • Careers
  • Face to Face Interviewer
© 2016 - 2025 Ipsos All Rights Reserved
  • Legal
  • Privacy & Data Protection
  • Cookie Policy
  • Tax Strategy
  • Modern Slavery Statement
  • Our Alert System